𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A formulation strategy for gamma secretase inhibitor ELND006, a BCS class II compound: Development of a nanosuspension formulation with improved oral bioavailability and reduced food effects in dogs

✍ Scribed by Kevin Quinn; Rampurna Prasad Gullapalli; Elaine Merisko-liversidge; Erich Goldbach; Angelina Wong; Gary G. Liversidge; Wherly Hoffman; John-michael Sauer; John Bullock; George Tonn


Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
317 KB
Volume
101
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.